Factbox: Billion-dollar lawsuits accuse drugmakers, distributors of fueling U.S. opioid crisis
(Reuters) – On Monday, two Ohio counties reached a last-minute settlement with four companies they accused of fueling the nationwide…
by October Gallery
(Reuters) – On Monday, two Ohio counties reached a last-minute settlement with four companies they accused of fueling the nationwide…
CLEVELAND (Reuters) – Four large drug companies reached a last-minute $260 million legal settlement over their role in the U.S.…
(Reuters Health) – People who were exposed to more sources of stress in the womb and early childhood may be…
(Reuters) – From the start of the sprawling U.S. litigation seeking to hold drugmakers and distributors liable for the country’s…
CLEVELAND (Reuters) – A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug…
(Reuters) – Five drugmakers and distributors are offering $22 billion in cash as well as drugs and services they value…
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz,…
(Reuters Health) – Certain psychiatric conditions may prompt some women to choose to have their ovaries removed even when there…
(Reuters Health) – Playing virtual reality games or relaxing in a virtual nature setting might help ease chronic pain, particularly…
(Reuters) – Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion…
(Reuters Health) – Patients who only briefly take opioid painkillers are still likely to face side effects, a new study…
(Reuters Health) – People with pets may be able to use their companion animals to practice techniques for managing chronic…
NORMAN, Okla. (Reuters) – Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson (JNJ.N) to a drug…
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd…
(Reuters) – An Oklahoma judge on Monday approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd…
(Reuters Health) – A class of medications used for nerve and muscle pain, including the popular drug Lyrica, increases users’…
(Reuters Health) – A class of medications used for nerve and muscle pain, including the popular drug Lyrica, increases users’…
(Reuters Health) – A smartphone-based relaxation app could help migraine sufferers reduce the number of headaches they get each month,…
(Reuters Health) – Listening to music at home may reduce cancer patients’ pain and fatigue and ease symptoms like loss…
(Reuters) – Lawyers for counties and municipalities suing drug manufacturers and distributors over their alleged roles in the U.S. opioid…
(Reuters) – The father of a college football player who died of a drug overdose gave emotional testimony about the…
(Reuters Health) – Dentists in the U.S. prescribe opioids at a rate 70 times higher than dentists in England, a…
NORMAN, Okla. (Reuters) – Johnson & Johnson’s greed led the drugmaker to use deceptive marketing to create an oversupply of…
BOSTON/JERUSALEM (Reuters) – Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with…
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad…
ATLANTA (Reuters) – U.S. President Donald Trump touted progress in the fight against opioid abuse on Wednesday and promised to…
Many women who suffer from menstrual symptoms like pain and heavy bleeding don’t tell their families or doctors about it…
(Reuters) – Oklahoma’s attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva…
(Reuters) – OxyContin maker Purdue Pharma LP and members of the wealthy Sackler family that own the company reached a…
(Reuters) – Purdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusing the OxyContin painkiller…
(Reuters Health) – Many middle-aged and older adults with torn cartilage and pain in their knee are not likely to…
(Reuters) – OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000…
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive…
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling…
(Reuters Health) – Postmenopausal women who experience problems like vaginal dryness, painful intercourse or urinary incontinence may want to see…
(Reuters Health) – Babies have long been offered a bit of sugar water or breastmilk to comfort them during needle…
(Reuters Health) – The vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of…
(Reuters Health) – Online black-market sales of opioid painkillers more than doubled in the United States during the two years…
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief…
(Reuters Health) – Narcotic painkillers can be particularly dangerous for patients who also take tranquilizing drugs known as benzodiazepines, but…